Necrotizing vasculitis secondary to disseminated histoplasmosis simulating pyoderma gangrenosum.

Detalles Bibliográficos
Publicado en:Rheumatology Vol. 52; no. 12; pp. 2304 - 2306
Autores principales: Vinicki, Juan P., Tiraboschi, Iris N., Fernandez, Daniel, Dubinsky, Diana, Laborde, Hugo A., Nasswetter, Gustavo
Formato: case study letter pictorial Journal Article
Publicado: Oxford University Press / USA Dec2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=92051429&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 92051429
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14620324
        DN9
      jtl: Rheumatology
      issn: 14620324
      maglogo: N
    pubinfo:
      dt: Dec2013
      vid: 52
      iid: 12
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        92051429
        104161423
        104161423
        10.1093/rheumatology/ket174
        92051429
      ppf: 2304
      ppct: 2
      formats:
      tig:
        atl: Necrotizing vasculitis secondary to disseminated histoplasmosis simulating pyoderma gangrenosum.
      aug:
        au:
          Vinicki, Juan P.
          Tiraboschi, Iris N.
          Fernandez, Daniel
          Dubinsky, Diana
          Laborde, Hugo A.
          Nasswetter, Gustavo
        affil: División Reumatología, Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina and División Infectología, Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
      sug:
        subj:
          Histoplasmosis Complications
          Vasculitis Risk Factors
          Diagnosis, Differential
          Pyoderma Gangrenosum Epidemiology
          Middle Age
          Female
          Immunosuppressive Agents
          Itraconazole Therapeutic Use
          Antibiotics
          Arthritis Drug Therapy
          Hematologic Tests Utilization
          Polymerase Chain Reaction Utilization
          Sensitivity and Specificity
          Middle Aged: 45-64 years
          Female
      pubtype: Academic Journal
      doctype:
        case study
        letter
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N